ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
64 hedge funds and large institutions have $48.9M invested in Zynerba Pharmaceuticals, Inc in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
12% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 17
Holders
64
Holding in Top 10
–
Calls
$2.57M
Puts
$2.32M
Top Buyers
| 1 | +$2.13M | |
| 2 | +$1.96M | |
| 3 | +$1.28M | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$1.05M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$750K |
Top Sellers
| 1 | -$1.32M | |
| 2 | -$1.25M | |
| 3 | -$865K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$557K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$505K |